Virios therapeutics to present at the bio ceo & investor conference

Atlanta--(business wire)--virios therapeutics, inc. (nasdaq: viri), a biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, announced today that greg duncan, chairman and chief executive officer, will present a company overview at the virtual 2021 bio ceo & investor conference to be held from february 16-18, 2021. the presentation will focus on the need for new approaches to treat fibromyalgia (“fm”
VIRI Ratings Summary
VIRI Quant Ranking